VTE Dublin Podcast 95 | Hunt | VITT the UK experience

VTE Dublin Podcast 94 | Swan | VITT the Irish experience

VTE Dublin Podcast 93 | Coutinho | Vaccine-induced thrombosis & thrombocytopenia presenting as cerebral vein & sinus thrombosis

VTE Dublin Podcast 92 | Samuelson-Bannow | Making decisions on duration following a hormone-provoked VTE event

VTE Dublin Podcast 91 | Scully | Advances in the management of thrombotic thrombocytopenic purpura

VTE Dublin Podcast 90 | Geersing | Diagnostic strategies in suspected PE across different healthcare setting

VTE Dublin Podcast 89 | Geersing | long-term risk of recurrent VTE in unprovoked VTE patients

VTE Dublin Podcast 88 | Anna Falanga | Hypercoagulability in myeloproliferative disorders

VTE Dublin Podcast 87 | Philip O’Halloran | VTE prophylaxis in TBI

VTE Dublin Podcast 86 | Katie White: Management of pregnant women with antithrombin deficiency

VTE Dublin Podcast 85 | Mandy Lauw: Update on the management of splanchnic vein thrombosis

VTE Dublin Podcast 84 | Agnes Lee: Treatment of cancer-associated thrombosis

VTE Dublin Podcast 83 | Cihan Ay: Optimal evaluation of recurrent VTE risk in cancer patients

VTE Dublin Podcast 82 | Alok Khorana: Prevention of Cancer-Associated Thrombosis

VTE Dublin Podcast 81 | Jean Connors: Trials addressing the role of anticoagulation in outpatients with COVID-19

VTE Dublin Podcast 80 | Nicole Kuderer: Cancer and COVID-19

VTE Dublin Podcast 79 | Michelle Sholzberg: Anticoagulation as a therapeutic strategy in hospitalized patients with COVID-19

VTE Dublin Podcast 78 | Rachel Rosovsky: The role of the PERT Team in 2021

VTE Dublin Podcast 77 | Beverly Hunt: World Thrombosis Day

VTE Dublin Podcast 76 | Rachel Rosovsky: VTE in COVID-19 the Boston experience